December 2024 Member Spotlight: Atterx

Join NIAMRRE as we highlight Atterx during the Member Spotlight on December 3, 2025, noon-1pm CT. The presentation will provide an overview Atterx's novel solutions currently in development. Their lead product, C-1205, uses bacterial interference to prevent catheter associated urinary tract infections (CAUTIs). Along with a description of how the technology works, compelling study results from treatment of human patients will be presented. Atterx's second product, GN-4474, is a topical that uses conjugation-killing technology to treat gram-negative bacterial infections. Attend this webinar to gain an understanding of their technology and view results from studies focused on human and in vivo experiments.